HARVONI is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) 1. genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis 2. genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin 3. genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin Active ingredients in HARVONI are: ledipasvir and sofosbuvir. Inactive ingredients in HARVONI are:colloidal silicon dioxide, copovidone, croscarmellose sodium, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. HARVONI (ledipasvir and sofosbuvir) tablets should be administered under the supervision of a qualified experienced physician.

Where can I buy Harvoni?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its presence PAN India with over 20 years of domain experience.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand HARVONI (ledipasvir and sofosbuvir) tablets on prescription and Import License in Patient's Name only.

For procurement of Harvoni or ledipasvir and sofosbuvir tablets.
Please contact at M: +91 9811747774 or Email Us
HARVONI (ledipasvir and sofosbuvir) tablets

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals HARVONI (ledipasvir and sofosbuvir) tablets can be made available at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Harvoni Brands In India

1. HARVONI (ledipasvir and sofosbuvir) tablets

For More Details

Dosage Forms and Strengths

Harvoni is available as Tablets: 90 mg ledipasvir and 400 mg sofosbuvir.